Core Laboratories Updates View on Long-Cycle Projects, Debt
Core Laboratories (ticker: CLB) gave its Q3 conference call yesterday, elaborating on some of the trends it sees with international activity improvement, its longer-cycle projects, and its debt agreement. Highlights from the Q3 Results for Core Laboratories: Revenue of $182.1 million, up 12% year-over-year Operating Margins of 19%; Ex-Items 20%, Up over 360 BPS year-over-year EPS of $0.50; $0.64 ex-items,